Empowered Funds LLC Raises Holdings in Concentrix Corporation $CNXC

Empowered Funds LLC increased its stake in shares of Concentrix Corporation (NASDAQ:CNXCFree Report) by 21.6% during the 1st quarter, Holdings Channel.com reports. The fund owned 306,784 shares of the company’s stock after purchasing an additional 54,585 shares during the quarter. Empowered Funds LLC’s holdings in Concentrix were worth $8,394,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. Larson Financial Group LLC lifted its position in Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after purchasing an additional 479 shares during the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the period. Global Retirement Partners LLC grew its holdings in shares of Concentrix by 1,032.5% in the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock worth $36,000 after purchasing an additional 795 shares during the last quarter. Webster Bank N. A. bought a new position in shares of Concentrix in the first quarter worth approximately $41,000. Finally, Rothschild Investment LLC increased its stake in shares of Concentrix by 52.0% in the fourth quarter. Rothschild Investment LLC now owns 1,146 shares of the company’s stock worth $48,000 after buying an additional 392 shares during the period. 90.34% of the stock is owned by hedge funds and other institutional investors.

Concentrix Stock Performance

Shares of CNXC stock opened at $24.60 on Friday. The stock has a fifty day moving average of $25.06 and a 200 day moving average of $29.20. Concentrix Corporation has a 52 week low of $19.12 and a 52 week high of $57.88. The firm has a market capitalization of $1.50 billion, a price-to-earnings ratio of -1.15, a PEG ratio of 0.46 and a beta of 0.47. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.46.

Concentrix (NASDAQ:CNXCGet Free Report) last released its quarterly earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing the consensus estimate of $2.64 by ($0.01). The company had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The business’s revenue was up 1.9% on a year-over-year basis. During the same quarter last year, the firm earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. As a group, research analysts expect that Concentrix Corporation will post 9.67 earnings per share for the current year.

Concentrix Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th will be given a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, July 24th. Concentrix’s dividend payout ratio (DPR) is currently -6.75%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CNXC. Zacks Research lowered shares of Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Barrington Research dropped their price target on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research report on Tuesday, June 30th. Canaccord Genuity Group cut their price target on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. Bank of America decreased their price objective on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research report on Tuesday, June 30th. Finally, Robert W. Baird lowered their price objective on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $32.75.

Read Our Latest Report on Concentrix

Concentrix Company Profile

(Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Read More

Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXCFree Report).

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.